Equities

Xlife Sciences AG

XLS:SWX

Xlife Sciences AG

Actions
  • Price (CHF)34.30
  • Today's Change0.00 / 0.00%
  • Shares traded2.75k
  • 1 Year change+3.94%
  • Beta--
Data delayed at least 15 minutes, as of Apr 25 2024 16:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.

  • Revenue in CHF (TTM)1.00m
  • Net income in CHF16.13m
  • Incorporated2013
  • Employees19.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Molecular Partners AG7.04m-61.98m116.38m168.00--0.5959--16.54-1.89-1.890.21475.370.0306--4.7441,892.86-26.91-11.83-28.90-14.69--99.28-880.70-45.30---70.970.0203---96.29-7.43-152.59---1.40--
Santhera Pharmaceuticals Holding AG5.16m-64.69m119.94m46.00------23.23-27.26-27.261.35-4.650.072334.233.54112,217.40-90.56-54.38-250.35-75.3429.3978.16-1,253.16-209.100.0778-2.29----568.53-20.10-27.87--23.14--
Newron Pharmaceuticals SpA8.86m-15.87m124.62m23.00------14.06-0.8896-0.88960.4966-1.640.2873--4.57385,311.70-51.45-37.10-111.53-43.9894.8091.72-179.13-270.48---2.862.62--48.6217.617.25---22.76--
Xlife Sciences AG1.00m16.13m195.62m19.0027.180.80777.34194.941.261.260.136842.470.0021--1.6852,815.792.25--2.88--30.17--1,062.47------0.1437--27.53---73.21------
Kuros Biosciences AG33.56m-13.73m254.01m80.00--4.47--7.57-0.3697-0.36970.91751.540.43472.407.27419,550.00-17.78-13.47-21.34-14.8471.3178.73-40.90-81.481.69-84.040.0364--86.61115.935.95---13.21--
Idorsia Ltd184.69m-374.06m328.97m1.36k------1.78-2.11-2.111.04-4.650.22010.237462.89135,698.00-44.59-43.40-62.30-48.0694.92---202.54-966.501.02-26.393.77--174.70-9.29-30.46--28.72--
Basilea Pharmaceutica AG Allschwil157.63m10.45m527.33m147.0045.92--43.763.350.87650.876513.15-0.83350.79991.065.161,072,340.005.30-1.867.69-2.9983.0083.456.63-2.992.642.021.10--6.683.53-13.96--11.17--
Polypeptide Group AG317.86m-50.33m955.48m1.20k--2.55--3.01-1.52-1.529.6011.310.51372.315.08264,446.60-8.132.59-10.373.262.8123.73-15.834.581.12-1.560.246615.7914.6012.36-762.29--25.40--
Data as of Apr 25 2024. Currency figures normalised to Xlife Sciences AG's reporting currency: Swiss Franc CHF

Institutional shareholders

1.82%Per cent of shares held by top holders
HolderShares% Held
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 202431.72k0.56%
UBS Asset Management Switzerland AGas of 02 Apr 202422.36k0.39%
Z�rcher Kantonalbank (Investment Management)as of 29 Feb 202412.69k0.22%
OFZL AGas of 31 Mar 202310.00k0.18%
CATAM Asset Management AGas of 31 Mar 20218.00k0.14%
Pictet Asset Management SAas of 31 Dec 20235.97k0.11%
BlackRock Asset Management Schweiz AGas of 04 Apr 20245.25k0.09%
Credit Suisse AGas of 31 Jan 20243.41k0.06%
Belvoir Capital AGas of 31 Oct 20232.36k0.04%
Gutmann Finanz Strategien AGas of 31 Dec 20232.05k0.04%
More ▼
Data from 31 Mar 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.